Milnacipran - Pierre Fabre
At a glance
- Drug Originator Pierre Fabre
- Drug Licenced by AbbVie; Asahi Kasei; Cypress Bioscience; Janssen Pharmaceutical KK; Sanofi
- Drug Class Amides; Amines; Analgesics; Antidepressants; Cyclopropanes; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 4
- NDAs 1
- International Patents 33
- Patent Applications 434

Disclaimer